PATENT CLAIM ANALYSIS

Application Number: 16426698
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-09
Patent Classification: ["514", "252150"]

Abstract:
The present invention is directed to spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1), that are useful in the treatment of diseases or disorders associated with peripheral serotonin including, for example, gastrointestinal, cardiovascular, pulmonary, inflammatory, metabolic, and low bone mass diseases, as well as serotonin syndrome, and cancer.

Claim (Index 13):
The method of  claim 11 , wherein inhalation is with a spray or an aerosol.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 100.0
- Lexical Diversity: 1.35294
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15278130', '15645054', '14477948', '14841868', '15978361']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8081108832859427
- 35 USC 102 Novelty (BERT): 0.5975098628282146
- Combined Prediction Score: 0.7870507812401699
- Mean Citation Score: 475.81637800000016
- Max Citation Score: 502.43924
- Similarity Product: 495.0207124698162

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test